Net Contents
60 Vegetarian Capsule(s)
Serving Size
1 Capsule(s)
Servings Per Container
Not specified
Supplement Form
Capsule
Bar Code (UPC/SKU)
0 48107 19233 4
Product Version
CODE 304211 FTG
Label Analysis
Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.
2 distinct active ingredients are disclosed in Supplement Facts.
Every active ingredient discloses a specific amount per serving.
This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.
Supplement Facts
Serving Size: 1 Capsule(s) · 2 per day
| Ingredient | Amount Per Serving | |
|---|---|---|
| TamaFlex | 125 mg | — |
| Tamarindus indica seed extract | — | — |
| Turmeric (Curcuma longa) rhizome extract | — | — |
| ApresFlex Boswellia serrata gum extract | 50 mg | — |
Not Present
Other Ingredients
Target Groups
Label Claims
Directions & Suggested Use
Suggested/Recommended/Usage/Directions
Directions: As a dietary supplement, take one capsule in the morning and one in the evening.
Warnings & Precautions
Precautions re: Pregnant or Nursing or Prescription Medications
Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.
Precautions re: All Other
Discontinue use two weeks prior to surgery.
Precautions re: Children
Keep out of reach of children.
Storage
Storage
Store in a cool, dry place.
FDA Statements
FDA Disclaimer Statement
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FDA Statement of Identity
Dietary Supplement
Other Label Statements
General Statements: All Other Content
Feel the difference in just 5 days
Brand IP Statement(s) re: (c), (TM), (SM)
TamaFlex is a trademark of NXT USA, Inc. Patents Pending. ApresFlex is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas-Laila Nutraceuticals LLC. U.S. Patent #8,551,496 and other patents pending.
General Statements: All Other Content
In a randomized, double-blind study, 67 adults took 50 mg of ApresFlex or a placebo twice daily. Those taking ApresFlex had improvements in joint stiffness, comfort and function (WOMAC) that were 5,7 and 43 times greater vs. the placebo group after 30 days. Improvements were seen as early as 5 days.
Manufacturer & Distributor
Distributor
General Nutrition Corporation
Pittsburgh, PA, 15222, USA
1-888-462-2548
Where to Buy Locally
Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.
Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2019-12-22. DSLD Label ID: 211789. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.
